BRONCHES TS
Food supplement declared in France, decision dated 4 November 2026
BRONCHES TS is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- SANTISLAB FRANCE SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 gélules
- Directions for use
- 1 gélules à prendre 3 fois par jour, avec un grand verre d'eau (250 ml), en fin de repas
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Heart problems, Ulcer (stomach or duodenum), Prolonged use, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Respiratory tract, Immunity
Declaration 376947, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cupressus sempervirens L. | Essence (rameaux) | Distillation | 60 mg |
| Thymus vulgaris L. | Essence (sommités fleuries) | Distillation | 45 mg |
| Eucalyptus radiata A.Cunn. ex DC. | Essence (rameaux) | Distillation | 45 mg |
| Melaleuca alternifolia (Maiden & Betche) Cheel | Essence (feuille) | Distillation | 30 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Sulfate de cuivre | Cuivre | 5,000 µg | 2,000 µg |
| Sulfate de manganèse | Manganèse | 8 mg (safe level) | 3.5 mg |
Additives
E493, E322
Other ingredients
Eau purifiée, Gélatine bovine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Réservé à l'adulte. Ne pas utiliser chez les femme enceintes et allaitantes. Déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancers hormonodépendants (cancer du sein). Risque d’interactions médicamenteuses, demandez conseil à un professionnel de santé en cas de prise simultanée de médicaments, en cas de troubles cardiaques, de défaut de la synthèse de l'hème hépatique (porphyrie), ou de troubles gastro-œsophagiens. Déconseillé en cas d'ulcère, d'inflammation du tractus digestif et de calculs biliaires. Ne pas utiliser en cas d’antécédents d’épilepsie ou convulsions. Déconseillé en cas d'allergie croisée connue, en particulier à la colophane. Pas d'usage régulier. Ne pas utiliser de manière prolongée (14 jours de prise maximum).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thymus vulgaris L.
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.